Most Researched Peptides
Not all peptides have equal research backing. This ranking evaluates peptides by the volume and quality of their published scientific evidence, from FDA-approved compounds with extensive clinical trials to preclinical peptides with promising animal data.
Our Ranking Criteria
Rankings
Semaglutide
Phase 4 (Post-Market)The most extensively researched peptide with massive STEP, SUSTAIN, PIONEER, and SELECT clinical trial programs involving tens of thousands of participants across multiple indications.
Pros
Cons
Tirzepatide
Phase 4 (Post-Market)Rapidly accumulating research through SURMOUNT and SURPASS trial programs. Already FDA-approved for two indications with additional studies ongoing for MASH, heart failure, and sleep apnea.
Pros
Cons
BPC-157
Preclinical (100+ studies)Over 100 preclinical publications spanning multiple tissue types and mechanisms. The most researched non-approved peptide, though all studies remain at the animal level.
Pros
Cons
Tesamorelin
Phase 4 (Post-Market)FDA-approved with extensive human clinical trial data. Research spans lipodystrophy, cognitive function, liver fat, and body composition.
Pros
Cons
Semax
Approved in RussiaDecades of Russian clinical research and government approval for multiple indications. While Western data is limited, the total research volume is substantial.
Pros
Cons
Methodology
Rankings are based on total published research volume, highest clinical trial phase achieved, number of independent research groups, and regulatory milestones. We distinguish between preclinical and clinical evidence quality.
Frequently Asked Questions
Why do some popular peptides have little research?
Many popular peptides like TB-500 and Epitalon lack commercial patent protection needed to justify expensive clinical trials. Research peptides often rely on academic labs with limited budgets.
Does more research mean a peptide is better?
More research means more certainty about effects and risks. Semaglutide has the most research because pharma investment funded massive trials. Less-studied peptides may have potential but carry more uncertainty.
Where can I find peptide research studies?
PubMed (pubmed.ncbi.nlm.nih.gov) is the primary database. ClinicalTrials.gov lists ongoing trials. Google Scholar provides broader coverage including preprints.